retatrutide glp-1 medication “Let’s talk — the newest multi-agonist making waves in metabolic medicine. This next-gen targets not one, not two, but three key receptors: GLP-1, GIP, and glucagon. The result? How Does Retatrutide Work? Triple
Description
Follow-up visits can be done over telehealth or in-clinic if youre in the area
Wegovy treatment plans are personalised, focusing on metabolic health, quality of life, and prevention of weightrelated complications
Evaluate weight loss at 12 weeks on the maintenance dose
Med Clin 2022
Hashimotos affects far more than thyroid hormone levels
According to Truveta Research presented at ISPOR 2025, side effects were the leading reason patients stopped taking GLP-1 medications, accounting for 28.2% of all discontinuations
